Eukaryotic expression of the core gene of hepatitis C virus genotype 1a
Archives of Medical Laboratory Sciences,
Vol. 3 No. 2 (2017),
16 October 2017
Background: Worldwide, hepatitis C virus (HCV) infection is a serious public health disease unlike hepatitis A and B, there is currently no vaccine against HCV available. Thus, extensive studies are under way to design new and effective treatments against HCV. Core protein is a component of HCV particle which is the first antigen recognized by the immune system.beside protective properties of core protein, anti –core antibodies can be used to monitor the disease progress. The purpose of the present study was to isolate and clone the core (C) gene from HCV genotype 1a in an attempt to construct a recombinant vector and subsequently evaluate its expression in a cell culture system.
Methods:RNA genome of HCV genotype 1a was extracted from the blood of an infected patient. Complementary DNA (cDNA) was synthesized. HCV 1a core gene was amplified by PCR using specific primers and it was cloned into a eukaryotic expression vector. Huh7.5 cells were transfected by the designed recombinant vector and the cellular expression of the core gene was confirmed by RT-PCR.
Results: Recombinant pcDNA3.1 (+) vector containing the HCV core gene with approximate size of 576bp was successfully designed. RT-PCR was used to confirm the expression of core antigen in an Huh7.5 cell line.
Conclusion: The results showed that the core gene was successfully isolated from HCV genotype 1a and was cloned into the eukaryotic expression vector. This recombinant vector effectively replicated in Huh7.5 cell line. and its protective and therapeutic effects can be examined in further investigations.
- Gene Expression
- Hepatitis C virus
How to Cite
(WHO) WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infectionApril 2014.
Alter MJ. Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology. 2007;13(7):2436-41.
Gerald L. Mandell, John E. Bennett, and Raphael Dolin. Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7 ed2010. 2157-78 p.
Casey Lc Fau - Lee WM, Lee WM. Hepatitis C virus therapy update 2013. Curr Opin Gastroenterol. 2013;29(3):243-9. eng.
Bartenschlager R, Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Research. 2001;52(1):1-17.
Frentzen A, Anggakusuma, Gurlevik E, Hueging K, Knocke S, Ginkel C, et al. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells. Hepatology. Jan;59(1):78-88. PubMed PMID: 23873628. Epub 2013/07/23. eng.
Sharma SD. Hepatitis c virus: Molecular biology & current therapeutic options. Indian Journal of Medical Research. 2010;131(1):17-34.
Feinstone SM, Hu DJ, Major ME. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus. Clinical infectious diseases. 2012;55(suppl 1):S25-S32.
Ajorloo M, Bamdad T, Hashempour T, Alborzi AM, Mozhgani SHR, Asadi R, et al. Detection of Specific Antibodies to HCV-ARF/CORE+ 1 Protein in Cirrhotic and Non-Cirrhotic Patients with Hepatitis C: A Possible Association with Progressive Fibrosis. Archives of Iranian Medicine (AIM). 2015;18(5).
Ali A, Nisar M, Idrees M, Rafique S, Iqbal M. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays. International Journal of Infectious Diseases. 2015;34:84-9.
Teimourpour R, Sadeghian A, Meshkat Z, Esmaelizad M, Sankian M, Jabbari AR. Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosis. Jundishapur J Microbiol. 2015;8(8):e21556. Epub 2015-08-29.
Teimourpour R, Meshkat Z, Gholoubi A, Nomani H, Rostami S. Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture System. Jundishapur J Microbiol. 2015;8(5):e19279. Epub 2015-05-31.
Teimourpour R, Sadeghian A, Meshkat Z, Esmaelizad M, Sankian M, Jabbari A-R. Construction of a DNA vaccine encoding Mtb32C and HBHA genes of Mycobacterium tuberculosis. Jundishapur journal of microbiology. 2015;8(8).
Sambrook J, Fritsch, E. F. & Maniatis, T. Molecular Cloning: a Laboratory Manual. 2 ed: Cold Spring Harbor; 2001.
Baghani A, Yousefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and construction a DNA vaccine encoding the fusion fragment of cfp10 and ag85a immunodominant genes of Mycobacterium tuberculosis. Iran J Microbiol. submitted foe publication.
Rashidian S, Derakhshan M, Teimourpour R, Meshkat Z. Designing and construction of a DNA vaccine encoding ag85a and tb10.4 fusion genes of Mycobacterium tuberculosis. Iran J Microbiol. submitted for publication.
Kim Cw Fau - Chang K-M, Chang KM. Hepatitis C virus: virology and life cycle. Clin Mol Hepatol. 2013 20130417;19(1):17-25. eng.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. Apr;57(4):1333-42. PubMed PMID: 23172780. Epub 2012/11/23. eng.
Iacovacci S, Manzin A, Barca S, Sargiacomo M, Serafino A, Valli MB, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology. 1997;26(5):1328-37.
Iacovacci S, Sargiacomo M, Parolini I, Ponzetto A, Peschle C, Carloni G. Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Research in Virology. 1993;144(4):275-9.
Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, et al. Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol. 2007 May;81(9):4405-11. PubMed PMID: 17301131. Epub 2007/02/16. eng.
Irshad M, Khushboo I, Singh S, Singh S. Hepatitis C virus (HCV): a review of immunological aspects. International reviews of immunology. 2008;27(6):497-517.
Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, et al. Production of infectious hepatitis C virus of various genotypes in cell cultures. Journal of virology. 2007;81(9):4405-11.
Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: implications for vaccine development. Hepatology. 1999;30(4):1088-98.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333-42.
Sharma SD. Hepatitis C virus: molecular biology & current therapeutic options. 2010.
Law LMJ, Landi A, Magee WC, Tyrrell DL, Houghton M. Progress towards a hepatitis C virus vaccine. Emerging microbes & infections. 2013;2(11):e79.
Li D, Huang Z, Zhong J. Hepatitis C virus vaccine development: old challenges and new opportunities. National Science Review. 2015:nwv040.
Irshad M, Dhar I. Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications. Medical Principles and Practice. 2006;15(6):405-16.
Ajorloo M BT, Hashempour T, Alborzi AM, Mozhgani SH, Asadi R, Haj-Sheykholeslami A, Merat S. Detection of Specific Antibodies to HCV-ARF/CORE+1 Protein in Cirrhotic and Non-Cirrhotic Patients with Hepatitis C: A Possible Association with Progressive Fibrosis. Arch Iran Med. 2015;18(5):304-7.
McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. Journal of viral hepatitis. 2000;7(1):2-14.
Ali A NM, Idrees M, Rafique S, Iqbal M. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays. Int J Infect Dis. 2015;34:84-9.
Irshad M Fau - Khushboo I, Khushboo I Fau - Singh S, Singh S Fau - Singh S, Singh S. Hepatitis C virus (HCV): a review of immunological aspects. Int Rev Immunol. 2008 20081209 DCOM- 20090324;27(6):497-517 eng.
S. Jane Flint LWE, Vincent R. Racaniello, Anna Marie Skalka. Principles of Virology: Pathogenesis and Control. 3 ed. Washington, DC ASM Press; 2009.
Dueñas‐Carrera S, Alvarez‐Lajonchere L, César Alvarez‐Obregón J, Pérez A, Acosta‐Rivero N, Vázquez DM, et al. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein‐encoding plasmids. Biotechnology and applied biochemistry. 2002;35(3):205-12.
Dueñas‐Carrera S, Viña A, Martínez R, Alvarez‐Lajonchere L, Alvarez‐Obregón JC, Marante J, et al. Immunization with a DNA vaccine encoding the hepatitis‐C‐virus structural antigens elicits a specific immune response against the capsid and envelope proteins in rabbits and Macaca irus (crab‐eating macaque monkeys). Biotechnology and applied biochemistry. 2004;39(2):249-55.
Alvarez‐Lajonchere L, Shoukry N, Gra B, Amador‐Cañizares Y, Helle F, Bédard N, et al. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of viral hepatitis. 2009;16(3):156-67.
Alvarez‐Lajonchere L, González M, Alvarez‐Obregón JC, Guerra I, Vina A, Acosta‐Rivero N, et al. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co‐delivered DNA vaccine encoding HCV structural antigens in mice. Biotechnology and applied biochemistry. 2006;44(1):9-17.
Alvarez-Obregón JC, Duenas-Carrera S, Valenzuela C, Grillo JM. A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice. Vaccine. 2001;19(28):3940-6.
Chakravarti A, Chauhan MS, Dogra G, Banerjee S. Hepatitis C virus core antigen assay: can we think beyond convention in resource limited settings? Brazilian Journal of Infectious Diseases. 2013;17(3):369-74.
Dawson GJ. The potential role of HCV core antigen testing in diagnosing HCV infection. Antivir Ther. 2012;17(7 Pt B):1431-5.
Gaudy C, Thevenas C, Tichet J, Mariotte N, Goudeau A, Dubois F. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. Journal of clinical microbiology. 2005;43(4):1722-6.
Long L, Shen T, Gao J, Duan Z, Liang H, Lu F. Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients. BMC infectious diseases. 2014;14(1):577.
- Abstract Viewed: 144 times
- PDF Downloaded: 132 times